Preferred Sequencing of Treatment for Neuroendocrine Tumors
Preferred Sequencing of Treatment for Neuroendocrine Tumors

Deepak Vadehra, DO, Tanios Bekaii-Saab, MD

Five Major Colorectal and GI Cancer Abstracts From 2025 ASCO
Five Major Colorectal and GI Cancer Abstracts From 2025 ASCO

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Cathy Eng, MD, FACP, FASCO

MATTERHORN Trial: Promising Results and Unanswered Questions
MATTERHORN Trial: Promising Results and Unanswered Questions

Deepak Vadehra, DO, Supriya Peshin, MD

Diverse Bispecific Strategies Emerging Across GI Cancers
Diverse Bispecific Strategies Emerging Across GI Cancers

Shruti Patel, MD, Udhayvir Singh Grewal, MD

Interpreting the Broad Cabozantinib Label for NETs
Interpreting the Broad Cabozantinib Label for NETs

Neena Vijayvergia, MD, Shruti Patel, MD

Considering Frontline PRRT in NETs
Considering Frontline PRRT in NETs

Neena Vijayvergia, MD, Shruti Patel, MD

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy
Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBS

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE
ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Sawyer Bawek, DO